ABVC BioPharma, Inc. Conversion of Stock, Shares Converted
ABVC BioPharma, Inc. (ECOC) reported Conversion of Stock, Shares Converted of 994.45 thousand shares for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-13.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesConverted1 · last filed 2025-08-13
- ABVC BioPharma, Inc. conversion of stock, shares converted for the quarter ending 2025-06-30 was 0.00 shares.
- ABVC BioPharma, Inc. conversion of stock, shares converted for the quarter ending 2025-03-31 was 994.45K shares.
- ABVC BioPharma, Inc. conversion of stock, shares converted for fiscal 2023 was 994.45K shares, a 0.00% change from fiscal 2022.
- ABVC BioPharma, Inc. conversion of stock, shares converted for fiscal 2022 was 994.45K shares.
| Period end | Conversion of Stock, Shares Converted 0 month | Conversion of Stock, Shares Converted 3 month | Conversion of Stock, Shares Converted 6 month | Conversion of Stock, Shares Converted 12 month |
|---|---|---|---|---|
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | 994.45K shares 10-Q · filed 2025-08-13 | ||
| 2025-03-31 | 994.45K shares 10-Q · filed 2025-04-30 | |||
| 2023-12-31 | 994.45K shares 10-K · filed 2024-03-13 | |||
| 2022-12-31 | 994.45K shares 10-K · filed 2025-04-15 | |||
| 2020-04-05 | 192.78K shares 10-Q · filed 2022-11-14 |